Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups
- PMID: 11515035
Item in Clipboard
Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups
J Natl Cancer Inst.
1970 Jan.
No abstract available
Similar articles
-
Nasopharyngeal carcinoma and Epstein-Barr virus. I. Factors related to the anti-VCA antibody.Jpn J Exp Med. 1973 Apr;43(2):121-33. Jpn J Exp Med. 1973. PMID: 4352111 No abstract available.
-
Epstein-Barr virus is not associated with head and neck neoplasms other than nasopharyngeal carcinoma.Neoplasma. 1982;29(3):327-31. Neoplasma. 1982. PMID: 6290911 No abstract available.
-
Nasopharyngeal carcinoma and Epstein-Barr virus. II. Clinical course and the anti-VCA antibody.Jpn J Exp Med. 1973 Apr;43(2):135-44. Jpn J Exp Med. 1973. PMID: 4352112 No abstract available.
-
Epstein-Barr virus and cancers of the head and neck.Am J Otolaryngol. 2001 May-Jun;22(3):197-205. doi: 10.1053/ajot.2001.23429. Am J Otolaryngol. 2001. PMID: 11351290 Review.
-
Epstein-Barr virus (EBV) associated lesions of the head and neck.Oral Dis. 1996 Jun;2(2):117-24. doi: 10.1111/j.1601-0825.1996.tb00211.x. Oral Dis. 1996. PMID: 8957923 Review. No abstract available.
Cited by
-
A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).PLoS Genet. 2013;9(1):e1003147. doi: 10.1371/journal.pgen.1003147. Epub 2013 Jan 10. PLoS Genet. 2013. PMID: 23326239 Free PMC article.
-
The characterization of the EBV alkaline deoxyribonuclease cloned and expressed in E. coli.Nucleic Acids Res. 1989 Oct 11;17(19):7609-22. doi: 10.1093/nar/17.19.7609. Nucleic Acids Res. 1989. PMID: 2552412 Free PMC article.
-
Mechanisms of infection with Epstein-Barr virus. I. Viral DNA replication and formation of noninfectious virus particles in superinfected Raji cells.J Virol. 1976 Jul;19(1):187-94. doi: 10.1128/JVI.19.1.187-194.1976. J Virol. 1976. PMID: 181594 Free PMC article.
-
The capsid antigen of Epstein-Barr virus in nasopharyngeal carcinomas: comparison of serum antibody titre, cellular antigen content and histopathology.Arch Otorhinolaryngol. 1984;239(1):15-23. doi: 10.1007/BF00454258. Arch Otorhinolaryngol. 1984. PMID: 6318710
-
Evaluation of Total and IgA-Specific Antibody Targeting Epstein-Barr Virus Glycoprotein 350 and Nasopharyngeal Carcinoma Risk.J Infect Dis. 2018 Aug 14;218(6):886-891. doi: 10.1093/infdis/jiy250. J Infect Dis. 2018. PMID: 29718378 Free PMC article.